Vetter Pharma International

Activities: Manufacturing Drug Delivery

Trending Articles

  1. NICE approves KEYTRUDA as first perioperative immunotherapy for locally advanced head and neck cancer MSD's KEYTRUDA (pembrolizumab) has received NICE approval as a neoadjuvant and adjuvant therapy for resectable LA HNSCC—the first immunotherapy recommended in this...
  2. Destination Russia for new NYK Logistics warehouse Logistics specialist NYK is expanding its market presence with the launch of new warehousing operation in Moscow, Russia.
  3. Pfizer agrees sale of consumer healthcare business to J&J Pfizer Inc has reached an agreement to sell its consumer healthcare business to Johnson & Johnson (J&J) for US$16.6bn (euro13.2bn) in cash.
  4. Pfizer's HYMPAVZI receives positive CHMP opinion for haemophilia A and B patients with inhibitors The EMA's Committee for Medicinal Products for Human Use has recommended expanding the approved indication for Pfizer's HYMPAVZI to include adolescents and adults with...
  5. AstraZeneca's tozorakimab meets primary endpoint in both Phase III COPD trials AstraZeneca has reported positive results from the OBERON and TITANIA Phase III trials, with tozorakimab significantly reducing moderate-to-severe COPD exacerbations compared...

Upcoming event

Making Pharmaceuticals

21–22 April 2026 | Exhibition | Coventry, UK See all

Related Content

Media

Vetter named CDMO of the Year in Finished Dose category at 2026 CDMO Leadership Awards

Vetter has received the Finished Dose award at the 2026 CDMO Leadership Awards, with recognition based on verified sponsor feedback and quantitative performance metrics, as the company advances around €2bn in planned capacity expansions through 2035
Manufacturing

Vetter Pharma to build new manufacturing site in Germany as part of €1.5bn global expansion plan

The company has submitted a building permit application for a new commercial manufacturing facility in Saarland, Germany, with construction set to begin in Q2 2026 and operations planned for 2031
Sustainability

Vetter achieves top sustainability rating and expands climate goal commitments

Recent recognitions reinforce Vetter’s continued investment in renewable energy projects
Packaging

Vetter reaches key launch milestones for the V-OVS next tamper-evident syringe closure system

Several recent steps move the closure toward commercialisation
Manufacturing

When the chemistry is right: Vetter expands capacities with a pure water generator from Pharmatec

The production of injectable active pharmaceutical ingredients (APIs) is a highly complex process that leaves no room for error
Design & Build

Vetter marks the start of new clinical site construction with groundbreaking ceremony

Pharmaceutical service provider expands its footprint in the greater Chicago area
Manufacturing

Vetter once again named best managed company

The award jury recognises strategic and sustainable corporate management
Subscribe now